塞库金单抗
医学
斑块性银屑病
银屑病
单克隆抗体
单克隆
白细胞介素
皮肤病科
银屑病性关节炎
免疫学
抗体
白细胞介素17
细胞因子
作者
Kristian Reich,Richard B. Warren,Mark Lebwohl,Melinda Gooderham,Bruce Strober,Richard Langley,C. Paul,Dirk De Cuyper,Veerle Vanvoorden,Cynthia Madden,Christopher L. Cioffi,Luke Peterson,Andrew Blauvelt
标识
DOI：10.1056/nejmoa2102383
摘要
Bimekizumab is a monoclonal IgG1 antibody that selectively inhibits both interleukin-17A and interleukin-17F. The efficacy and safety of bimekizumab as compared with secukinumab, which selectively inhibits interleukin-17A alone, in patients with moderate-to-severe plaque psoriasis have not been extensively examined.
科研通智能强力驱动
Strongly Powered by AbleSci AI
PDF的下载单位、IP信息已删除
彭于彦祖
Lignin
SYLH
枫叶
shuang0116
ED
herococa
yznfly
CR7
研友_Y59785
pcr163
shinysparrow
挖掘机
pluto
愉快的真
粗犷的嘉熙
酷炫的咖啡豆
鸣笛
CAOHOU
柯一一
皖公网安备34019202002308
